4Filing Date: Feb 24, 2026

Zimmer Biomet (ZBH)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001783992-26-000002
Total Value$0
Trades1
Insiders1

Transaction Details

Thornal Kevin R
Grp Pres-Global Business·Direct
Grant · Acquire
Restricted Stock UnitsDerivative
Shares+27.39K
Price$0.00
Total Value$0
Shares Owned After27.39K
Transaction DateFeb 20, 2026
Footnotes ▸

Each RSU represents a contingent right to receive one share of Company common stock. | Vests annually over three years in increments of one-third each year, commencing February 20, 2027. | Vests annually over three years in increments of one-third each year, commencing February 20, 2027.

Post-Transaction Holdings

Thornal Kevin R · Grp Pres-Global Business
SecuritySharesChange
Restricted Stock Units27.39K+27.39K
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-02-20 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: ZIMMER BIOMET HOLDINGS, INC. (ZBH) CIK: 0001136869 --- Reporting Owner --- Name: Thornal Kevin R CIK: 0001783992 Role: Officer (Grp Pres-Global Business) --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-02-20 | Code: A (Grant or award) Shares: +27,385 | Price: $0.00 Shares Owned After: 27,385 | Ownership: D (Direct) Footnotes: [F1] Each RSU represents a contingent right to receive one share of Company common stock. [F2] Vests annually over three years in increments of one-third each year, commencing February 20, 2027. [F2] Vests annually over three years in increments of one-third each year, commencing February 20, 2027. --- Footnotes (Complete Index) --- F1: Each RSU represents a contingent right to receive one share of Company common stock. F2: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. --- Signature --- /s/ /s/ Matthew R. St. Louis, Attorney-in-Fact for Kevin Thornal (power of attorney previously filed) (2026-02-24)

keid analysis is for reference only and does not constitute investment advice.